• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[综合癌症中心的患者合作关系:患者与照护者委员会的设立及职责]

[Patient-partnership in a comprehensive cancer centre: Establishment and roles of a patients and caregivers committee].

作者信息

De Jesus Anne, Faveur Anne, Garnier Lydia, Servant Claire, Le Bars Sabrina, Cousin Gérard, Dagorne Patrick, De La Rocque France, Delgrange Stéphane, Guidy Corinne, Manighetti Joëlle, Roux Raimonda, Sazy Thérèse, Scull Isabelle, Terrade Catherine, Turkel Liliane, Veret Fabienne, Escudier Bernard, Billard Camélia, Rieutord André, Khoury Jane, Blot François

机构信息

Comité de patients et aidants, Gustave-Roussy, université Paris-Saclay, 114, rue Édouard-Vaillant, 94800 Villejuif, France; Relation avec les usagers, direction de la qualité et patientèle ; Gustave-Roussy, université Paris-Saclay, 114, rue Édouard-Vaillant, 94800 Villejuif, France; Comité d'éthique, Gustave-Roussy, université Paris-Saclay, 114, rue Édouard-Vaillant, 94800 Villejuif, France.

Comité de patients et aidants, Gustave-Roussy, université Paris-Saclay, 114, rue Édouard-Vaillant, 94800 Villejuif, France.

出版信息

Bull Cancer. 2024 Jun;111(6):576-586. doi: 10.1016/j.bulcan.2024.02.010. Epub 2024 Apr 24.

DOI:10.1016/j.bulcan.2024.02.010
PMID:38664089
Abstract

In oncology, the place of patients has a natural and strong legitimacy. Cancer is a common disease, with many singularities but also common features between pathologies, with issues ranging from prevention to possible palliative phases or post-cancer, and conducive to both individual and collective decision-making processes. Patient engagement is now essential at all levels of the healthcare system, from simple information to real involvement (co-construction). For 20 years, Gustave-Roussy, a comprehensive cancer centre in Villejuif, has implemented specific reflection and actions, embodied by the creation of a patients and caregivers committee and complemented by an institutional steering body that illustrates the transformation of "working for" into "working with". At the level of direct care, the main works promoted concern shared-decision-making between patient and professional and accompanying patients. At the institutional level, we find the expertise of hospital projects or services, the development of institutional documents (information and advance directives form, etc.), and internal evaluation (audit). At the political level, participation in Unicancer's patient-experience working group has allowed for a better coordinated deployment with other centers. Unicancer has developed a lexical guide defining patient resources, peer helpers, trainers, evaluators and coordinators. This partnership approach is beneficial for patients, their loved ones, caregivers, and must be amplified and give rise to new research work.

摘要

在肿瘤学领域,患者的地位具有天然且强大的合理性。癌症是一种常见疾病,虽有诸多独特之处,但不同病理类型之间也存在共同特征,涉及从预防到可能的姑息治疗阶段或癌症康复后的各种问题,有利于个人和集体的决策过程。如今,患者参与在医疗体系的各个层面都至关重要,从简单的信息告知到真正的参与(共同构建)。二十年来,位于维勒瑞夫的综合性癌症中心古斯塔夫 - 鲁西一直开展具体的思考与行动,成立患者及照护者委员会体现了这些思考与行动,此外还有一个机构指导机构,它诠释了从“为患者工作”到“与患者合作”的转变。在直接护理层面,主要推动的工作涉及患者与专业人员之间的共同决策以及陪伴患者。在机构层面,我们能看到医院项目或服务的专业知识、机构文件(信息及预立医疗指示表格等)的制定以及内部评估(审核)。在政策层面,参与联合国癌症研究机构的患者体验工作组有助于与其他中心进行更协调的部署。联合国癌症研究机构制定了一份词汇指南,对患者资源、同伴协助者、培训人员、评估人员和协调人员进行了定义。这种合作方式对患者、他们的亲人、照护者都有益处,必须加以推广并催生新的研究工作。

相似文献

1
[Patient-partnership in a comprehensive cancer centre: Establishment and roles of a patients and caregivers committee].[综合癌症中心的患者合作关系:患者与照护者委员会的设立及职责]
Bull Cancer. 2024 Jun;111(6):576-586. doi: 10.1016/j.bulcan.2024.02.010. Epub 2024 Apr 24.
2
[What place for an Ethics committee in a comprehensive cancer centre? For an ethics embodied in real life].伦理委员会在综合癌症中心应处于何种地位?论现实生活中所体现的伦理
Bull Cancer. 2019 Dec;106(12):1144-1151. doi: 10.1016/j.bulcan.2019.06.008. Epub 2019 Oct 5.
3
A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.对所有医疗环境中共同决策的内部和外部影响进行的定性系统评价。
JBI Libr Syst Rev. 2012;10(58):4633-4646. doi: 10.11124/jbisrir-2012-432.
4
[Implementation of a multimodal strategy for information and collection of advance directives in a comprehensive cancer center].
Bull Cancer. 2023 Jun;110(6):635-645. doi: 10.1016/j.bulcan.2023.02.017. Epub 2023 Mar 22.
5
Rationalizing the Influence of Co-Design on Distress, Clinical Decision-Making and Disease Self-Management of Cancer Patients-as-Partners: A Quasi-Experimental Study.使癌症患者作为合作伙伴的困扰、临床决策和疾病自我管理受共同设计的影响合理化:一项准实验研究。
Health Expect. 2024 Jun;27(3):e14113. doi: 10.1111/hex.14113.
6
Shared decision-making needs, barriers, and facilitators of patients with newly diagnosed advanced cancer in the hospital: a multi-level, mixed-methods study.新诊断为晚期癌症的住院患者的共享决策需求、障碍和促进因素:一项多层次混合方法研究。
Support Care Cancer. 2024 Apr 29;32(5):315. doi: 10.1007/s00520-024-08515-1.
7
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.不同种族文化群体成年癌症患者的姑息治疗体验:一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809.
8
Anticancer centres in France.法国的抗癌中心。
Aust N Z J Surg. 1979 Jun;49(3):374-7.
9
Commentary on: "Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial." Kwon ED, Drake CG, Scher HI, Fizazi K, Bossi A, van den Eertwegh AJ, Krainer M, Houede N, Santos R, Mahammedi H, Ng S, Maio M, Franke FA, Sundar S, Agarwal N, Bergman AM, Ciuleanu TE, Korbenfeld E, Sengeløv L, Hansen S, Logothetis C, Beer TM, McHenry MB, Gagnier P, Liu D, Gerritsen WR, CA184-043 Investigators. Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA, Electronic address: kwon.eugene@mayo.edu; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA; Institut Gustave Roussy, University of Paris-Sud, Villejuif, France; Institut Gustave Roussy, Villejuif, France; VU University Medical Centre, Amsterdam, Netherlands; Vienna General Hospital, Medical University Vienna, Vienna, Austria; Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France; Centro Médico Austral, Buenos Aires, Argentina; Centre Jean Perrin, Clermont-Ferrand, France; St John of God Hospital, Subiaco, WA, Australia; University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy; Hospital de Caridade de Ijuí, Ijuí, Brazil; Nottingham University Hospital, Nottingham, UK; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania; Hospital Británico de Buenos Aires, Buenos Aires, Argentina; Herlev Hospital, Herlev, Denmark; Odense University Hospital, Odense, Denmark; University of Texas MD Anderson Cancer Center, Houston,关于“多西他赛化疗后进展的转移性去势抵抗性前列腺癌患者放疗后伊匹木单抗与安慰剂对比研究(CA184 - 043):一项多中心、随机、双盲、3期试验”的述评。权恩东(Kwon ED)、德雷克·C·G(Drake CG)、舍尔·H·I(Scher HI)、菲扎齐·K(Fizazi K)、博西·A(Bossi A)、范登·埃尔特韦赫·A·J(van den Eertwegh AJ)、克莱纳·M(Krainer M)、胡德·N(Houede N)、桑托斯·R(Santos R)、马哈梅迪·H(Mahammedi H)、吴思(Ng S)、马约·M(Maio M)、弗兰克·F·A(Franke FA)、桑达尔·S(Sundar S)、阿加瓦尔·N(Agarwal N)、伯格曼·A·M(Bergman AM)、丘莱亚努·T·E(Ciuleanu TE)、科尔本费尔德·E(Korbenfeld E)、森格洛夫·L(Sengeløv L)、汉森·S(Hansen S)、洛戈塞蒂斯·C(Logothetis C)、比尔·T·M(Beer TM)、麦克亨利·M·B(McHenry MB)、加尼耶·P(Gagnier P)、刘丹(Liu D)、格里特森·W·R(Gerritsen WR),CA184 - 043研究团队。美国明尼苏达州罗切斯特市梅奥诊所泌尿外科、免疫学系及梅奥诊所综合癌症中心,电子邮箱:kwon.eugene@mayo.edu;美国马里兰州巴尔的摩市约翰·霍普金斯西德尼·金梅尔综合癌症中心及布雷迪泌尿外科研究所;美国纽约州纽约市纪念斯隆凯特琳癌症中心及威尔康乃尔医学院;法国巴黎 - 萨克雷大学古斯塔夫·鲁西研究所,维勒瑞夫;法国古斯塔夫·鲁西研究所,维勒瑞夫;荷兰阿姆斯特丹VU大学医学中心;奥地利维也纳医科大学维也纳总医院;法国波尔多贝戈涅研究所;法国尼姆卡勒莫医院;阿根廷布宜诺斯艾利斯澳大利亚医学中心;法国克莱蒙费朗让·佩兰中心;澳大利亚西澳大利亚州苏比亚科圣若翰医院;意大利锡耶纳大学医院、托斯卡纳肿瘤研究所;巴西伊茹伊慈善医院;英国诺丁汉大学医院;美国犹他州盐湖城犹他大学亨茨曼癌症研究所;荷兰阿姆斯特丹荷兰癌症研究所及安东尼·范·列文虎克医院;罗马尼亚克卢日 - 纳波卡肿瘤研究所及尤利乌·哈蒂根努医科药学院;阿根廷布宜诺斯艾利斯英国医院;丹麦赫勒夫医院;丹麦欧登塞大学医院;美国得克萨斯大学MD安德森癌症中心,休斯顿
10
'Working the system'. Achieving change through partnership working: an evaluation of cancer partnership groups.“利用系统”。通过合作实现变革:对癌症合作组织的评估
Health Expect. 2005 Sep;8(3):210-20. doi: 10.1111/j.1369-7625.2005.00332.x.
Urol Oncol. 2016 May;34(5):249-50. doi: 10.1016/j.urolonc.2015.03.013. Epub 2015 Apr 20.